Want to join the conversation?
$SYK CEO Kevin Lobo said the company expects its sales momentum to continue in 2016 and is targeting organic sales growth for the year of 5-6%. He also added that the two-year suspension of the med device tax provides $SYK with the opportunity to bolster investments that will help drive sales growth and innovation.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?